RIXIMYO

Google image searchProduct monograph

Active ingredient

rituximab, 10 MG/ML

DIN: 02498316

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIALS

Schedule: Prescription / Schedule D

Company: SANDOZ CANADA INCORPORATED

Date: 22-MAY-2020

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FA — CD20 (Clusters of Differentiation 20) inhibitors (ATC, ATC/DDD)
• L01FA01 — RITUXIMAB (ATC/DDD)

Reference brand drug: Rituxan

External Links for Riximyo

Search on Google

• Riximyo side effects
• Riximyo dosage
• rituximab side effects
• rituximab dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find riximyo photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.